Patents by Inventor Yasuhito Funahashi

Yasuhito Funahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883438
    Abstract: It is an object to provide a technique useful for embryo transfer and development of reproductive medical care. Provided are a sperm activator containing a disrupted product of one or more cells selected from the group consisting of adipose tissue-derived stem cells, dental pulp-derived stem cells, bone marrow-derived stem cells, and umbilical cord blood-derived stem cells as an active ingredient, and an artificial insemination method utilizing the same.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: January 30, 2024
    Assignees: National University Corporation Nagoya University, Gifu University, Gifu Prefecture
    Inventors: Tokunori Yamamoto, Satoshi Suzuki, Yasuhito Funahashi, Yoshihisa Matsukawa, Momokazu Gotoh, Tomohiro Kitayama, Yoichiro Hoshino, Tetsuma Murase
  • Publication number: 20190240260
    Abstract: It is an object to provide a technique useful for embryo transfer and development of reproductive medical care. Provided are a sperm activator containing a disrupted product of one or more cells selected from the group consisting of adipose tissue-derived stem cells, dental pulp-derived stem cells, bone marrow-derived stem cells, and umbilical cord blood-derived stem cells as an active ingredient, and an artificial insemination method utilizing the same.
    Type: Application
    Filed: August 23, 2017
    Publication date: August 8, 2019
    Inventors: Tokunori Yamamoto, Satoshi Suzuki, Yasuhito Funahashi, Yoshihisa Matsukawa, Momokazu Gotoh, Tomohiro Kitayama, Yoichiro Hoshino, Tetsuma Murase
  • Patent number: 9226926
    Abstract: A method of treating a condition chosen from the group consisting of interstitial cystitis, cystitis, chronic nonbacterial prostatitis, chronic cystitis, prostatic hyperplasia, prostatitis, prostatism, bladder neck contracture, bladder inflammation, and overactive bladder by administering an amount of rebamipide or a pharmaceutically acceptable salt thereof to a human.
    Type: Grant
    Filed: December 26, 2013
    Date of Patent: January 5, 2016
    Assignee: N.M.A. CO., LTD.
    Inventors: Tomohiro Ueda, Yasuhito Funahashi
  • Publication number: 20150099778
    Abstract: A method of treating a condition chosen from the group consisting of interstitial cystitis, cystitis, chronic nonbacterial prostatitis, chronic cystitis, prostatic hyperplasia, prostatitis, prostatism, bladder neck contracture, bladder inflammation, and overactive bladder by administering an amount of rebamipide or a pharmaceutically acceptable salt thereof to a human.
    Type: Application
    Filed: December 26, 2013
    Publication date: April 9, 2015
    Applicant: N.M.A. Co., Ltd.
    Inventors: Tomohiro Ueda, Yasuhito Funahashi
  • Publication number: 20140314724
    Abstract: An object is to provide a novel medical use of adipose tissue-derived mesenchymal stem cells. It was discovered that adipose tissue-derived mesenchymal stem cells (ASC) promote improvement of erectile dysfunction and recovery of the urge to urinate (improvement of sensory disorders of the lower urinary tract). On the basis of the discovery, a cell preparation containing adipose tissue-derived mesenchymal stem cells, which is effective to erectile dysfunction or sensory disorders of the lower urinary tract, is provided. In one embodiment, adipose tissue-derived mesenchymal stem cells and body fat are used in combination.
    Type: Application
    Filed: July 1, 2014
    Publication date: October 23, 2014
    Inventors: Tokunori Yamamoto, Naoshi Koide, Yoshifumi Takei, Yoshihisa Matsukawa, Yasuhito Funahashi, Momokazu Gotoh
  • Patent number: 8808688
    Abstract: An object is to provide a novel medical use of adipose tissue-derived mesenchymal stem cells. It was discovered that adipose tissue-derived mesenchymal stem cells (ASC) promote improvement of erectile dysfunction and recovery of the urge to urinate (improvement of sensory disorders of the lower urinary tract). On the basis of the discovery, a cell preparation containing adipose tissue-derived mesenchymal stem cells, which is effective to erectile dysfunction or sensory disorders of the lower urinary tract, is provided. In one embodiment, adipose tissue-derived mesenchymal stem cells and body fat are used in combination.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: August 19, 2014
    Assignee: National University Corporation Nagoya University
    Inventors: Tokunori Yamamoto, Naoshi Koide, Yoshifumi Takei, Yoshihisa Matsukawa, Yasuhito Funahashi, Momokazu Gotoh
  • Publication number: 20120244130
    Abstract: An object is to provide a novel medical use of adipose tissue-derived mesenchymal stem cells. It was discovered that adipose tissue-derived mesenchymal stem cells (ASC) promote improvement of erectile dysfunction and recovery of the urge to urinate (improvement of sensory disorders of the lower urinary tract). On the basis of the discovery, a cell preparation containing adipose tissue-derived mesenchymal stem cells, which is effective to erectile dysfunction or sensory disorders of the lower urinary tract, is provided. In one embodiment, adipose tissue-derived mesenchymal stem cells and body fat are used in combination.
    Type: Application
    Filed: September 7, 2010
    Publication date: September 27, 2012
    Applicant: National University Corporation Nagoya University
    Inventors: Tokunori Yamamoto, Naoshi Koide, Yoshifumi Takei, Yoshihisa Matsukawa, Yasuhito Funahashi, Momokazu Gotoh